BB Biotech AG

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2023🗂️ Report periods on file: 2023

In its 2023 reporting, BB Biotech AG disclosed greenhouse gas emissions of 801 tCO2e/year (2023). By scope: Scope 1: 32 tCO2e/year (2023); Scope 2: 44 tCO2e/year (2023); Scope 3: 725 tCO2e/year (2023). Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
801 tCO2e/year (2023)
2023

📊 Emissions by Scope (2023)

ScopeWhat it coversReported value
Scope 1Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions).32 tCO2e/year (2023)
Scope 2Indirect emissions from purchased electricity, steam, heat and cooling.44 tCO2e/year (2023)
Scope 3Other indirect emissions across the value chain (purchased goods, business travel, use of sold products, etc.).725 tCO2e/year (2023)

New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.

✅ Reported Environmental Achievements

🎯 Climate & Sustainability Targets

📅 Medium-term

  • Reduce CO2 emissions per employee (FTE) by 30% by 2030 (Investment Manager).

🔭 Long-term

  • Net zero emissions by 2050 (Investment Manager).

🌱 ESG Focus Areas

Financial solidity and delivering long-term total returns to shareholdersCO2 emissions reductionCorporate governance and business ethicsTransparencyDiversity and inclusionEmployee development and retentionEmployee engagementResponsible investing/Sustainable products

⚠️ Challenges & Risks +

  • Challenging year on many fronts.
  • Navigating volatile capital markets and higher capital costs.
  • ESG rating methodologies are based on predefined systematics that do not lead to an objective or “fair” risk assessment in all cases, especially for small-capitalized and young companies.

📋 Report Information

Reporting Period: 2023
Frameworks: GRI Standards
Assurance: Deloitte AG